These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22552839)

  • 1. Mechanisms of apoptosis by the tumor suppressor Par-4.
    Hebbar N; Wang C; Rangnekar VM
    J Cell Physiol; 2012 Dec; 227(12):3715-21. PubMed ID: 22552839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.
    Burikhanov R; Zhao Y; Goswami A; Qiu S; Schwarze SR; Rangnekar VM
    Cell; 2009 Jul; 138(2):377-88. PubMed ID: 19632185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine apoptotic effect of p53 mediated by tumor suppressor Par-4.
    Burikhanov R; Shrestha-Bhattarai T; Hebbar N; Qiu S; Zhao Y; Zambetti GP; Rangnekar VM
    Cell Rep; 2014 Jan; 6(2):271-7. PubMed ID: 24412360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Par-4 inhibits non-autochthonous tumor growth.
    Zhao Y; Burikhanov R; Brandon J; Qiu S; Shelton BJ; Spear B; Bondada S; Bryson S; Rangnekar VM
    Cancer Biol Ther; 2011 Jul; 12(2):152-7. PubMed ID: 21613819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and tumor resistance conferred by Par-4.
    Zhao Y; Rangnekar VM
    Cancer Biol Ther; 2008 Dec; 7(12):1867-74. PubMed ID: 18836307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.
    Burikhanov R; Shrestha-Bhattarai T; Qiu S; Shukla N; Hebbar N; Lele SM; Horbinski C; Rangnekar VM
    Cancer Res; 2013 Jan; 73(2):1011-9. PubMed ID: 23204231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis.
    Burikhanov R; Hebbar N; Noothi SK; Shukla N; Sledziona J; Araujo N; Kudrimoti M; Wang QJ; Watt DS; Welch DR; Maranchie J; Harada A; Rangnekar VM
    Cell Rep; 2017 Jan; 18(2):508-519. PubMed ID: 28076793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-selective apoptosis by tumor suppressor par-4.
    Hebbar N; Shrestha-Bhattarai T; Rangnekar VM
    Adv Exp Med Biol; 2014; 818():155-66. PubMed ID: 25001535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-selective apoptotic effects of extracellular and intracellular Par-4.
    Shrestha-Bhattarai T; Rangnekar VM
    Oncogene; 2010 Jul; 29(27):3873-80. PubMed ID: 20440265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU.
    Kline CL; Shanmugavelandy SS; Kester M; Irby RB
    Cancer Biol Ther; 2009 Oct; 8(19):1831-7. PubMed ID: 19729995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4.
    Rah B; Amin H; Yousuf K; Khan S; Jamwal G; Mukherjee D; Goswami A
    PLoS One; 2012; 7(9):e44039. PubMed ID: 22962598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of Par-4 combined with cisplatin on human Wilms' tumor cells.
    Wang J; Li Y; Ma F; Zhou H; Ding R; Lu B; Zou L; Li J; Lu R
    Tumour Biol; 2017 Jul; 39(7):1010428317716689. PubMed ID: 28720068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation.
    Ahmed MM; Sheldon D; Fruitwala MA; Venkatasubbarao K; Lee EY; Gupta S; Wood C; Mohiuddin M; Strodel WE
    Int J Cancer; 2008 Jan; 122(1):63-70. PubMed ID: 17893871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1.
    Guo H; Treude F; Krämer OH; Lüscher B; Hartkamp J
    Sci Rep; 2019 Jun; 9(1):8755. PubMed ID: 31217499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis.
    Joshi J; Fernandez-Marcos PJ; Galvez A; Amanchy R; Linares JF; Duran A; Pathrose P; Leitges M; Cañamero M; Collado M; Salas C; Serrano M; Moscat J; Diaz-Meco MT
    EMBO J; 2008 Aug; 27(16):2181-93. PubMed ID: 18650932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRP78 signaling hub a receptor for targeted tumor therapy.
    Sato M; Yao VJ; Arap W; Pasqualini R
    Adv Genet; 2010; 69():97-114. PubMed ID: 20807604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of protease-activated receptor-1-dependent and -independent responses to thrombin in skeletal myoblasts.
    de Niese MR; Chinni C; Pike RN; Bottomley SP; Mackie EJ
    Exp Cell Res; 2002 Mar; 274(1):149-56. PubMed ID: 11855866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.
    Darmoul D; Gratio V; Devaud H; Lehy T; Laburthe M
    Am J Pathol; 2003 May; 162(5):1503-13. PubMed ID: 12707033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet
    Liu C; QiNan W; XiaoTian L; MengLiu Y; XiaGuang G; WeiLing L; ZiWen L; Ling Z; GangYi Y; Bing C
    J Diabetes Res; 2018; 2018():7653904. PubMed ID: 30186877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cancer cell survival by Par-4.
    Ranganathan P; Rangnekar VM
    Ann N Y Acad Sci; 2005 Nov; 1059():76-85. PubMed ID: 16382046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.